|
HY-13018-10mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-100mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-5mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-50mg
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13018-1mL
|
MedChemexpress LLC
|
MRT67307 [CAS 1190378-57-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1052A-1mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1052A-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1052A-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-N0608-10mg
|
MedChemexpress LLC
|
Myrislignan [CAS 171485-39-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0608-5mg
|
MedChemexpress LLC
|
Myrislignan [CAS 171485-39-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0608-50mg
|
MedChemexpress LLC
|
Myrislignan [CAS 171485-39-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-113332-100mg
|
MedChemexpress LLC
|
Myristoleic acid [CAS 544-64-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-10mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-100mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-5mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-50mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-1mL
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-131992-10mg
|
MedChemexpress LLC
|
N-Acetylpsychosine [CAS 35823-61-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-120504-10mg
|
MedChemexpress LLC
|
N-Acetyltyramine [CAS 1202-66-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120504-5mg
|
MedChemexpress LLC
|
N-Acetyltyramine [CAS 1202-66-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120504-1mL
|
MedChemexpress LLC
|
N-Acetyltyramine [CAS 1202-66-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P7267-10ug
|
MedChemexpress LLC
|
NAP-2/CXCL7, Human (CHO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P7267-50ug
|
MedChemexpress LLC
|
NAP-2/CXCL7, Human (CHO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P99035-1mg
|
MedChemexpress LLC
|
Naptumomab [CAS 1412892-09-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-P99035-10mg
|
MedChemexpress LLC
|
Naptumomab [CAS 1412892-09-1]
|
|
COVID-19-immunoregulation
|
|
